The relevance of therapeutic drug monitoring in plasma and erythrocytes in anti-cancer drug treatment

Source
Clinical chemistry and laboratory medicine - ISSN 1434-6621-42:11 (2004) p. 1219-1227
Author(s)
    Herlinde Dumez, Gunther Guetens, Gert De Boeck, Martin S. Highley, Robert A.A. Maes, Allan T. van Oosterom, Ernst de Bruijn

Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion

Source
The British journal of cancer - ISSN 0007-0920-82:5 (2000) p. 1000-1003
Author(s)
    J.H.W. de Wilt, T.L.M. ten Hagen, Gert De Boeck, S.T. van Tiel, E.A. de Bruijn, A.M.M. Eggermont

Simultaneous determination of the peptide-mitomycin KW-2149 and its metabolites in plasma by high-performance liquid chromatography

Source
Journal of chromatography : biomedical applications - ISSN 0378-4347-739:2 (2000) p. 281-289
Author(s)
    Z. Zhang, Gunther Guetens, Gert De Boeck, Karel van Cauwenberghe, Rémy Maes, C. Ardiet, Allan T. van Oosterom, Ernst de Bruijn

Isolated hypoxic hepatic perfusion with tumor necrosis factor-alpha, melphalan, and mitomycin C using balloon catheter techniques : a pharmacokinetic study in pigs

Source
Annals of surgery - ISSN 0003-4932-228:6 (1998) p. 763-770
Author(s)
    Marc G.A. van Ijken, Ernst de Bruijn, Gert De Boeck, Timo L.M. ten Hagen, Joost R.M. van der Sijp, Alexander M.M. Eggermont